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NUTRITIONAL INTERVENTION IN OVERWEIGHT AND OBESE PATIENTS 
Posea Mihaela, PhD
 
National Institute of Diabetes, Nutrition and Metabolic Diseases “N. C. Paulescu”, Bucharest 
Background and Aims. Obesity is a major risk factor for type 2 diabetes, cardiovascular 
diseases, cancer, pulmonary diseases, osteoporosis. Our study aimed to evaluate the caloric intake, 
vitamins and minerals from food before a nutritional intervention to overweight and obese patients. 
Material and methods. We evaluated the content of food before running a nutritional 
intervention program of 124 overweight and obese patients . We assessed the kilocalories, vitamins 
and minerals from intake food using a 7-day weighed food self-records; measured resting metabolic 
rate after eight hours fasting with an indirect calorimeter and parameters like weight, body mass 
index, body fat, percent of body fat, abdominal circumference and arterial tension. 
Results. Considering a normal percent of body fat (PBF) for women between 20 and 30 and 
for men between 15 and 20, the mean value of PBF in group B, was significant higher in women 
than men (p<0.00001). Also women have significantly more often values of abdominal 
circumference over normal. Overweight and obese patients had an excessive intake of sodium, iron 
and selenium. They had an inadequate intake of D and E vitamins (less than 90% of recommended 
daily intake) and A, B1, B2, B3, B5, B6, B12 and C vitamins (more than 110% of recommended 
daily intake). After the nutritional intervention, overweight and obese patients had significantly 
lower level of intake carbohydrates (P=.018), lipids (P=.002), B1 vitamin (P<.001), B3 vitamin 
(P=.02) and E vitamin (P=.016). There is a significantly increased level of proteins (P<.001). The 
intake levels of following‘s decreased: sodium (P<.001), magnesium (P=.006), zinc (P=.035), 
copper (P=.002), manganese (P<.001). Phosphorus is the only mineral of which the intake level 
increased significantly (P<.001). All the anthropometric parameters decreased significantly: weight 
(P<.001), body mass index (P<.001), body fat (P<.001), percent of body fat (P<.001), abdominal 
circumference (P<0.001), systolic arterial tension (P<.001), diastolic arterial tension (P=.002). 
Conclusions. All the patients had imbalanced intake of vitamins and minerals both before 
and after intervention. We need to pay more attention to food quality and quantity during low 
caloric diet, thus to assure the recommended daily intake for vitamins and minerals. 
 
 
COMPARISON OF EFFICACY AND SAFETY OF LONG-TERM WARFARIN THERAPY 
IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION 
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Scientific research supervisor: Pristupa L.N., professor 
     Sumy State University, Department of Internal Medicine postgraduate education 
      Introduction: Anticoagulation with vitamin K antagonist (VKA) has been an enduring gold 
standard for stroke prevention in atrial fibrillation (AF). But the potential for serious bleeding 
complications of the drug remains a problem for the safe use of drug 
      Aim: Examine the prevalence of thromboembolic and bleeding complications in patients 
with non-valvular atrial fibrillation who receiving warfarin.  
      Metarials and methods: A total of 40 patients with non-valvular atrial fibrillation were 
recruited between July 2015 and January 2016 and were provided written informed consent. They 
were divided on two groups: firsts group of patients who did not take warfarin and second group of 
patients who took warfarin.  We used CHA2DS2VASc score to assess the risk of thromboembolic 
complications (TEC), scale HAS-BLED to assess the risk of bleeding, control of laboratory 
parameters. Patients who taking warfarin, was calculated time spent in the target range (TTR) of 
International Normalized Ratio (INR).Participants also completed a questionnaire about their 
vitamin K-rich beverage and food intake. 
      Results: The majority of patients (72%) were aged from 65 to 70 years. Patients, who taking 
warfarin, INR time (2-3) arranged from 78 to 82%. Patients  with high risk of thromboembolic 
complications (more than 5 points)of  CHA2DS2VASS scale was significantly more in patients, 
who were not  taking warfarin (18%) compared with patients, who received warfarin (p = 0.011). 
The majority of patients had a high risk of bleeding (more than 3 balls) on a HAS-BLED scale. 
